Industry in brief | Nestlé Health Science, Akorn, Hypera

2 September 2020 - Deborah Wilkes

Archived

Nestlé Health Science is acquiring Aimmune Therapeutics, Akorn has received court approval for its sale to the company’s existing lenders, and Hypera Pharma has released financial results.

Click tags below for more information on topics:

Nestlé Hypera Pharma Akorn

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: